Helen Sabzevari - May 12, 2021 Form 4 Insider Report for PRECIGEN, INC. (PGEN)

Role
President and CEO, Director
Signature
/s/ Helen Sabzevari, by Donald P. Lehr, as attorney-in-fact
Stock symbol
PGEN
Transactions as of
May 12, 2021
Transactions value $
-$303,571
Form type
4
Date filed
5/14/2021, 06:43 PM
Next filing
Jun 28, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PGEN Common Stock Options Exercise +97.3K +14.85% 752K May 12, 2021 Direct F1
transaction PGEN Common Stock Sale -$304K -47.4K -6.3% $6.40 705K May 13, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PGEN Restricted Stock Units Options Exercise $0 -97.3K -100% $0.00* 0 May 12, 2021 Common Stock 97.3K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ('RSU") represents a contingent right to receive one share of Precigen common stock.
F2 This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of RSUs.
F3 The RSUs were granted on March 25, 2021 and have vested in full.